Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis

Circulation

Volumn 94, Issue 12, 1996, Pages 3232-3238

  Yokoyama, Ikuo ^a   Ohtake, Tohru ^a   Momomura, Shin Ichi ^a   Nishikawa, Junichi ^a   Sasaki, Yasuhito ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

blood flow; hypercholesterolemia; stenosis; tomography

Indexed keywords

AMMONIA; ANTILIPEMIC AGENT; CHOLESTEROL; DIPYRIDAMOLE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN 13; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0030454110     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3232     Document Type: Article

References (32)

1. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34:48-55.
2. Camici PG, Chiriatti G, Lorenzoni R, Beluna RC, Gistri R, Italiani G. Coronary vasodilation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 1991;17:879-886.
3. Inoue T, Sasaki Y, Morooka S, Hayashi T, Takayanagi K, Yamanaka T, Kakoki H, Takabatake Y. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993;125:93-98.
4. Nitenberg A, Valensi P, Sachs R, Dalim M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal ventricular systolic function. Diabetes. 1993;32:1017-1023.
5. Nahser PJ Jr, Brown RE, Oskarsson H, Winnifold MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 1995;91:635-640.
6. Uren NG, Crake T, Leffery DC, Suva R, Gavies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222-227.
7. Yokoyama I, Ohtake T, Murakami T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med. In press.
8. Dayanikli F, Grambow D, Muzil O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90:808-817.
9. Goldstein JL, Dana SE, Brunschede GY, Brown MS. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutation affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A. 1975;72:1092-1096.
10. Mabuchi H, Tanami R, Haba T, Ueda K, Oota M, Takeguchi T, Wakasugi T, Takeda R. Cause of death in patients with familial hypercholesterolemia. Atherosclerosis. 1986;61:1-6.
11. Mabuchi H, Koizumi J, Shimizu M, Takeda R, Hokuriku FH, CHD Study Group. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989;79:225-232.
12. Heiberg A. The risk of atherosclerotic vascular disease in subjects with xanthomatosis. Acta Med Scand. 1975;198:249-261.
13. Beaumont V, Jacotot B, Beaumont JL. Ischemic disease in men and women with familial hypercholesterolemia and xanthomatosis: a comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis. 1976;24:441-450.
14. Jensen J, Blankenhom DH, Kornerup V. Coronary artery disease in familial hypercholesterolemia. Circulation. 1967;36:77-82.
15. Stone NJ, Levy RI, Fredrickson DS, Verter J. Coronary artery disease in 116 kindred with type II hyperlipoproteinemia. Circulation. 1974;49:476-488.
16. Kwiterovich PO Jr, Levy RI, Fredrickson DS. Neonatal diagnosis of familial type II hyperlipoproteinemia. Lancet. 1973;1:118-121.
17. Slach J. Risk of ischemic heart disease in familial hyperlipoproteinaemic states. Lancet. 1969;2:1380-1383.
18. Krivokapitch J, Smith GT, Huang SC, Hoffmen EJ, Raitib O, Phelps ME, Schelbert HR. 13N-ammonia myocardial imaging at rest and with exercise in normal volunteers. Circulation. 1989;80:1328-1337.
19. Seiler C, Hess OM, Buechi H, Suten TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors in vasomotion of angiographically normal coronary arteries. Circulation. 1993;88:2139-2148.
20. Osborne JA, Siegman MJ, Sedar AW, Mooers SU, Lefer AM. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol. 1989;256:C591-C597.
21. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1549.
22. Zeiher AM, Drexler H, Wollschlaeger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
23. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo: focus on hypercholesterolemia. Hypertension. 1991;18(suppl II):II-90-II-99.
24. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic patients. Circulation. 1990;81:1586-1593.
25. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
26. Bull H, Fret HRL, Jordeans FH, Herman AG. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide. Eur J Pharmacol. 1991;199:1-8.
27. Czernin J, Muller P, Chan S, Brunken RC, Porenta GP, Krivokapitch J, Chen K, Chan A, Phelps ME, Scheiben HR. Influence of age and hemodynarnics on myocardial blood flow and flow reserve. Circulation. 1993;88:62-69.
28. Kuhle WG, Porenta G, Huang SC, Buxton DB, Gambhir SS, Hansen H, Phelps ME, Scherbert HR. Quantification of regional myocardial blood flow using 13N-ammonia and reoriented dynamic positron emission tomography. Circulation. 1992;86:1004-1017.
29. Hutchins G, Schwaiger M, Rosenspire KC, Krivokapitch J, Scheiben HR, Kuhl DE. Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
30. Iida H, Tamaki N. Cardiac PET Working Group, Japan: quantitative assessment of regional myocardial blood flow using O-15 water and PET. J Nucl Med. 1995;36:78P. Abstract.
31. Seiler C, Kirkeeide K, Gould KL. Basic structure-function relationship of the epicardial coronary tree: basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation. 1992;85:1987-2003.
32. Rozanski A, Diamond GA, Forrester JS, Berman DS, Morris D, Swan JC. Alternative referent standard for cardiac normality: implication for diagnostic testing. Ann Intern Med. 1984;101:164-171.